Ticker Scorecard - ATAI Basics Company: Atai Life Sciences N.V. IPO Date: June 18, 2021 Sector: Healthcare Industry: Biotechnology Market Cap: $386.05M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 3.78% Avg Daily Range (30 D): $0.11 | 5.96% Avg Daily Range (90 D): $0.08 | 4.95% Institutional Daily Volume Avg Daily Volume: 1M Avg Daily Volume (30 D): 3.43M Avg Daily Volume (90 D): 2.16M Trade Size Avg Trade Size (Sh.): 197 Avg Trade Size (Sh.) (30 D): 331 Avg Trade Size (Sh.) (90 D): 306 Institutional Trades Total Inst.Trades: 100 Avg Inst. Trade: $1.56M Avg Inst. Trade (30 D): $.95M Avg Inst. Trade (90 D): $.96M Avg Inst. Trade Volume: .32M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.15M Avg Closing Trade (30 D): $.95M Avg Closing Trade (90 D): $.96M Avg Closing Volume: 681.18K     News Feb 13, 2025 @ 3:47 AM atai Life Sciences Announces Pricing of Public Off... Source: N/A Jan 22, 2025 @ 6:00 PM 5-HT2 Agonist Clinical Trial Pipeline Appears Robu... Source: Delveinsight Aug 6, 2024 @ 7:13 PM 4 Psychedelic Stocks to Consider as Clinical Trial... Source: Professor Ari Zoldan Jun 26, 2024 @ 11:00 AM atai Life Sciences to Participate in the H.C. Wain... Source: atai Life Sciences Jun 20, 2024 @ 11:00 AM atai Life Sciences Announces Update on Beckley Psy... Source: atai Life Sciences Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.8 $-.16 $-.36 Diluted EPS $-.8 $-.16 $-.36 Revenue $ .33M $ .04M $ .27M Gross Profit $ $ $ Net Income / Loss $ -130.2M $ -26.31M $ -57.37M Operating Income / Loss $ -105.99M $ -22.6M $ -25.73M Cost of Revenue $ $ $ Net Cash Flow $ -31.56M $ 10.39M $ -10.7M PE Ratio